Moleculin Biotech, Inc.
MBRX
$0.5697
-$0.0051-0.89%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.06% | 80.36% | -54.51% | -13.28% | -35.54% |
| Total Receivables | -16.67% | -70.00% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 276.45% | -48.14% | -74.33% | -9.05% | 13.46% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -68.98% | 300.30% | -- | -- | -- |
| Total Current Assets | -2.83% | 79.82% | -55.25% | -15.48% | -27.57% |
|
|
|||||
| Total Current Assets | -2.83% | 79.82% | -55.25% | -15.48% | -27.57% |
| Net Property, Plant & Equipment | -10.67% | -9.95% | -8.91% | -8.05% | -5.95% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 2.76% | 24.15% | -27.65% | -8.53% | -17.09% |
|
|
|||||
| Total Accounts Payable | 37.51% | 33.30% | -20.39% | -9.99% | 34.65% |
| Total Accrued Expenses | -0.05% | 26.71% | 9.63% | 4.50% | -12.33% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.23% | 3.33% | 3.45% | 3.57% | 2.75% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 14.75% | 28.68% | -4.18% | -2.66% | 6.25% |
|
|
|||||
| Total Current Liabilities | 14.75% | 28.68% | -4.18% | -2.66% | 6.25% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -10.43% | -8.94% | -8.21% | -7.14% | -6.67% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 49.49% | 162.94% | -47.35% | 482.86% | -49.88% |
| Total Liabilities | 37.13% | 91.59% | -31.22% | 102.22% | -14.99% |
|
|
|||||
| Common Stock & APIC | 0.27% | 0.31% | 0.27% | 0.22% | 0.27% |
| Retained Earnings | -4.78% | -4.20% | -1.24% | -7.52% | -3.16% |
| Treasury Stock & Other | 0.00% | 7.32% | -1,125.00% | 140.00% | 44.44% |
| Total Common Equity | -17,159.52% | -99.30% | -20.06% | -57.76% | -17.98% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -17,159.52% | -99.30% | -20.06% | -57.76% | -17.98% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -17,159.52% | -99.30% | -20.06% | -57.76% | -17.98% |
|
|
|||||